Activatable Persistent Luminescence from Porphyrin Derivatives and Supramolecular Probes with Imaging‐Modality Transformable Characteristics for Improved Biological Applications. Issue 24 (3rd February 2022)

• Record Type: Journal Article
• Authors: Duan, Xingchen; Zhang, Guo‐Qiang; Ji, Shenglu; Zhang, Yiming; Li, Jun; Ou, Hanlin; Gao, Zhiyuan; Feng, Guangxue; Ding, Dan
• Is Part Of: Angewandte Chemie international edition. Volume 61:Issue 24(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-02-03
• Subjects: Drug Screening -- Image-Guided Surgery -- Persistent Luminescence -- Porphyrin Derivatives -- Supramolecular Self-Assembly; Chemistry -- Periodicals; 540
• DOI: 10.1002/anie.202116174
• Languages: English
• ISSNs: 1433-7851

Abstract

Abstract: Persistent luminescence without excitation light and tissue autofluorescence interference holds great promise for biological applications, but is limited by available materials with long‐wavelength emission and excellent clinical potential. Here, we report that porphyrin derivatives can emit near‐infrared persistent luminescence over 60 min after cessation of excitation light or on interaction with peroxynitrite. A plausible mechanism of the successive oxidation of vinylene bonds was demonstrated. A supramolecular probe with a β‐sheet structure was constructed to enhance the tumor targeting ability and the photoacoustic and persistent luminescence signals. Such probes featuring light‐triggered function transformation from photoacoustic imaging to persistent luminescence imaging permit advanced image‐guided cancer surgery. Furthermore, peroxynitrite‐activated persistent luminescence of the supramolecular probe also enables rapid and precise screening of immunogenic cell death drugs. Abstract : Porphyrin derivatives that can emit near‐infrared persistent luminescence (PL) over 60 min are reported and a mechanism for the phenomenon is proposed. The derivatives are used to synthesize supramolecular probes with peroxynitrite‐activated PL and light‐triggered imaging‐modality transformation characteristics that permit improved biological uses.